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Physiotherapists need to be informed about the 
nature of HIV infection and AIDS, both as care 
providers and in terms of occupational health 
and safety. An overviewofthe natural history of 
the human immunodeficiency virus and the 
consequences of infection is given. Safety pro-
cedures are outlined and the contribution that 
physiotherapists can make to the health main-
tenance of HIV infected patients is briefly de-
scribed. 
[Coates R: HIV infection and AIDS: A guide for 
physiotherapists. Australian Journal of Physio-
therapy36: 17-21, 1990) 
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HIV infection and AIDS: A 
guide for physiotherapists 
The plethora of literature on the human immunodeficiency virus 
(lllV) and acquired immune 
deficiency syndrome (AIDS) would 
lead one to believe that there is no 
need for yet another article. It is 
evident, however, that many people, 
both lay and professional, tend to 
ignore the literature because they 
believe the issue does not relate to 
them (Anderson and Mayon-White 
1987, Hastings et al 1987). 
There is a need for physiotherapists 
to have a basic understanding of the 
natural history of the virus, the conse-
quences of infection, infection preven-
tion and the treatment of infected 
people. 
Physiotherapists must have this 
knowledge in order to be able to 
educate and counsel their patients, to 
protect themselves from infection and 
to provide appropriate treatment for 
infected people. 
It is the responsibility of all health 
professionals to familiarise themselves 
with the facts and issues associated 
with HN infection and AIDS in order 
to make a contribution to the overall 
public health management of the 
disease and to provide individual care 
and attention where appropriate. 
The myths, misunderstandings and 
fears that many people have can only 
be ameliorated through a sustained and 
responsible approach on the part of 
health authorities and those people 
working in the health and welfare 
professions. 
The virus and theimmllne system 
It has been established that the 
human immunodeficiency virus (fIIV) 
is responsible for AIDS (Mortimer 
1987). We know now that in the 1970s 
HIV was spreading in the Western 
world and that by 1981, when AIDS 
was first recognised, cases had .already 
occurred in several countries. The 
possible scope of the epidemic was not 
recognised until the mid 1980s and it is 
only since that time that global strateg-
ies for prevention have been develop-
ed. 
The folklore regarding the origin of 
the virus is colourful but there is no 
clear evidence, to date, of its actual 
origin. It would appear that the virus 
has been infecting humans for at least 
20 years. However, it is possible that 
earlier, unrecognised infections 
occurred. 
The first discovery of the virus was 
made in 1983 by Madame Francoise 
Barre-Sinoussi at the Pasteur Institute 
in Paris. The virus was first described 
as a retrovirus and named the lymph-
adenopathy associated virus (LA V). 
In 1984, Popovic, Gallo and associ-
ates in the United States described a 
virus which they called the human T-
lymphotropic virus type ill (HTL V-
III). The virus described by Barre-
Sinoussi and the one .described by 
Popovic et al are now considered to be 
the same virus which in May 1986 was 
named the human immunodeficiency 
virus (lllV) by agreement of the inter-
national Committee on the Taxonomy 
of Viruses. 
The human immunodeficiency virus 
is classified as a retrovirus because it 
contains the enzyme reverse tran-
scriptase which allows DNA to be 
transcribed from RNA. The virus 
targets specific human cells, namely 
the T -lymphocytes of the immune 
system and several types of cells in the 
central nervous system (McArthur and 
Johnson 1988). 
It has recently been stated that mv 
antibodies are produced in the central 
nervous system of all infected subjects 
and that infection ofT-lymphocyteS 
and the central nervous system occurs 
simultaneously (Lloyd, Robertson et al 
1988). . 
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The cellular immune system com-
prises the thymus-dependent (I) 
lymphocytes and the bone marrow-
dependent (B) lymphocytes. 
The helper-inducer cells known as 
T4 cells are a functionally distinct 
subset of the T -lymphocytes. These 
have been called the "leader of the im-
munological orchestra" because they 
playa central role in the body's im-
mune response. 
Under usual circumstances, the 
introduction of an antigen will result in 
activation and proliferation of the 
lymphocytes. The T4 cells divide and 
produce lymphokines which act as 
local hormones to facilitate an immune 
response through 'helping' the other T 
and B cells to proliferate. 
The T4 cells carry on their surface a 
glycoprotein molecule known as CD4, 
which has been shown to bifld with a 
glycoprotein found·on the surface of 
the mv (Beverley and Sattentau 
1987). The CD4 might be likened to a 
keyhole into which the viral glycopro-
tein fits like a key. The CD4 molecule 
has also been detected in brain cells 
and this provides a possible explanation 
for the invasion of this area. 
Once resident in the host cell, the 
virus is stripped of its glycoprotein coat 
and the reverse transcriptase copies the 
viral RNA into DNA. The DNA·then 
enters the nucleus of the host cell 
where it becomes incorporated into 
that cell's DNA. 
This is the critical factor that makes 
the virus a permanent part of the 
infected person's own cells. 
A period of quiescence ensues until 
the T4 cells are called upon to multi-
ply. When this occurs, the latent viral 
genes are activated and the mv begins 
to replicate. 
In order to do this, the viral genes 
need to use material from the host cell, 
thereby destroying it. The virus not 
only multiplies, but it destroys the host 
T4 cells, thus causing a profound 
breakdown in the inunune system. 
Antibodies to the virus are produced 
three weeks to three months after 
exposure and may be detected through 
blood tes~, but.the titre·ofthe anti-
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bodies is too low to affect the progress 
of the infection. 
The period between initial exposure 
to the virus and the development of 
antibodies is termed the "window 
period". The window period gives rise 
to some of the problems associated 
with the issue of mandatory testing of 
certain groups of people, for example 
overseas visitors. If an individual is 
tested during the window period, he or 
she will test negative. 
The pattern of infectiol\. 
Following exposure to the virus, an 
individual may be asymptomatic or 
may have a glandular fever type acute 
infection. The symptoms may include 
fever, malaise, sore throat, lymphad-
enopathyand muscle and joint pains. 
Reversible neurological signs and 
symptoms have also been described as 
occurring in approximately 10 per cent 
of patients during the initial acute 
phase. These include encephalitis, 
myelopathy, acute neuropathy, mood 
change, changes in the level of con-
sciousness, and fits (Rosenblum et al 
1988). 
After the seroconversion illness, the 
infected individual may remain symp-
tom free for several years. During this 
latent stage the individual can infect 
others through the exchange of body 
fluids such as blood or semen. 
Although estimates vary, approx-
imately 60 per cent of infected people 
will develop symptoms within about 
three years and within five to seven 
years will have developed frank AIDS. 
InJanuary 1988, Australia adopted a 
new system for classifying the stages of 
the infection. The system was pro-
posed by the Centers for Disease Con-
trol in the United States and is now 
used throughout the Western 'World. 
The classifications are as.follows: _ 
GROUP I Acute mv ~on 
This is the classification for newly-
infected people who may showsymp-
tomsofan acute, transitory illness. 
Tests for antibodies at this stage are 
usually negative. All patients in this 
groupretover from the acute illness 
and are then reclassified. Many people 
go through this phase without knowing 
they have become infected. 
GROUP n Asymptomatic mv 
infection 
This group includes all persons who 
are found to be mv antibody positive 
but have no apparent illness. Although 
asymptomatic, people in this group are 
infective. 
GROUP ill Persistent general-
ised lymphadenopathy 
People in this group have persistent 
lymph gland enlargement that cannot 
be explained by other causes. 
GROUP IV AIDS and related 
conditions 
This group includes all cases some-
times described as "full blown AIDS". 
People in this group have one or more 
of the serious illnesses that have 
become most commonly associated 
with AIDS, such as pneumocystis CIlrinii 
pneumonia, Kaposi's sarcoma and 
meningitis. 
Group IV is divided into a number of 
sub-groups including the following: 
patients with neurological diseases, the 
most commonly seen being encephali-
tis, meningitis, demyelination, retinitis, 
myelopathy, peripheral neuropathy 
and dementia (Rosenblum et alI988); 
patients with secondary infections, 
including pneumocystis CIlrinii pneumo-
nia (PCP), secondary cancers, gastro-
intestinal and liver diseases. 
Also included in Group IV are those 
with systemic symptoms such as fever, 
night sweats, unexplained weight loss 
and diarrhoea. 
To date, the prognosis for all patients 
in Group IV has been poor. 
Diagnosis 
Although a blood test to confirm the 
presence ofmv antibodies is the 
definitive diagnostic procedure, it is 
nevertheless important that a full 
history is taken, to ascertain at-risk be-
haviours and co-factors, and that a . 
thorough physical~ati.on and an 
evaluation of the integrity of the . 
immune system are conducted. Info-
rmation derived from these procedures 
will confirm the .accuracy of the 
antibody test. 
At-risk behaviours are defined as 
frequent, unprotected sexual activities, 
sharing needles for the injection of 
intravenous drugs and a history of 
multiple sexual partners. Co-factors 
include a history of venereal disease, 
hepatitis B and cytomegalovirus 
infections. 
The blood test 
The tests are highly specific and a 
system of checks is employed to avoid 
the possibility of false positives. The 
tests used in this country are the 
Western blot and the enzyme-linked 
immunosorbent assay (ELISA). 
It is important to note that a person 
may be recorded as antibody-negative 
if he or she is tested within three 
months of exposure to the virus (i.e. 
during the window period). It is there-
fore necessary, if there is reason to 
suspect that the person has recently 
been exposed to the virus, for there to 
be a follow-up test three months after 
the first one. The person should be 
counselled and strongly encouraged to 
refrain from engaging in any at-risk 
activities during this period in order to 
avoid both passing on the infection and 
being infected. 
Pre and post-test counselling is 
strongly advised and is conducted as a 
matter of routine at special facilities 
such as the sexually transmissible 
diseases clinics throughout the country 
and the Albion Street Clinic in Sydney 
(a facility devoted to the treatment and 
prevention of HIV infection and 
AIDS). Pre-test counselling is aimed at 
m,inimising the psycho-social conse-
quences if the result is positive and 
preparing patients, where appropriate, 
for changes to their lifestyle, irrespec-
tive of the test results. 
After a positive result, post-test 
counselling is aimed at helping the 
patient and those close to them to live 
as healthily as possible with HIV 
infection. Counselling will include the 
provision of information on leading a 
physically healthy lifestyle as well as 
the psychological support necessary. 
Referrals to a wide range of self-help 
and community groups are also pro-
vided. The reaction of patients to a 
positive test result is frequently charac-
terised by shock and despair. Support 
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from community groups is essential at 
this time, especially if the patient is not 
prepared to reveal his or her antibody 
status to friends or family. 
Post-test counselling for the person 
with a negative result is aimed at 
reassuring the individual and educating 
him or her about at-risk behaviours 
and safer lifestyle practices. 
It is not necessary for asymptomatic 
people or those with mild symptoms 
(Group III) to be absent from work. 
There are few activities which cannot 
be undertaken by an infected person. 
However, antibody-positive health 
care workers should not work in areas 
where there is a risk of their being 
exposed to virulent infections or where 
they might place patients at risk. It is 
important to remember that the mode 
of transmission for the virus is through 
the direct exchange of blood, blood 
products and semen. 
Treatment 
To date the only treatment available 
in Australia which is specific to reduc-
ing the impact of the virus, is the drug 
zidovudine (formerly called azido-
thymidine, hence the abbreviation 
AZT). Treatment with AZT of both 
asymptomatic patients and those with 
symptoms appears to retard progress 
toward significant immunodeficiency 
(Creagh-Kirk and Doi, 1988). 
However, long-term treatment with 
·AZT may have a toxic effect on some 
patients. Early treatment of asympto-
matic patients appears to be the most 
effective and should be sufficient 
reason for encouraging those who 
believe they might be at risk to seek 
counselling, testing and, where neces-
sary, treatment. 
Other drugs are under review and 
being used experimentally in other 
countries. Undoubtedly these will 
become available in this country in the 
near future. 
Other treatment is specific to the 
nature of the opportunistic infections 
such as the lung and gastro-intestinal 
diseases which may be treated with 
antibiotics. 
More recently, it has been recognized 
that preventative health care has an 
important role to play. Attentton to 
diet, the cessation of smoking and a 
reduction of intake of alcohol and 
other drugs can all help to raise the 
health status of the patient. Regular 
physical activity has also proved to be 
beneficial and physiotherapy has been 
demonstrated to have an important 
role in this. This is discussed below. 
The physiotherapist and control of 
infection 
It is inevitable that hospital-based 
physiotherapists will encounter pat-
ients with HIV infection. As time goes 
on, it is also likely that the physiother-
apist in private practice will, knowingly 
or unknowingly, encounter HIV 
infected patients. 
The risk of contracting the infection 
from a patient, during the normal 
course of duties, is estimated to be 
between 0.1 per cent and 0.9 per cent 
(Marcus 1988, McEvoy et al 1987, 
Henderson et al 1986, Kline et al 
1985). 
Staff may contract the virus through 
blood spurts from an infected person 
into skin lesions, the eye or the mouth, 
or through needlestick or other 
injuries from sharp instruments. A 
fresh spill of infected blood or semen 
could be a source of transmission if a 
worker has a skin lesion and comes 
into direct contact immediately after 
the spill. 
It has been reported that the virus has 
a limited life-span when exposed to the 
air (MMWR 1987). In an extensive 
study on the survival of HIV which 
involved concentrations 100,000 times 
greater than that typically found in the 
blood of infected patients, the rate of 
inactivation was found to be rapid with 
between 90 per cent and 99 per cent 
reduction in concentration within 
hours. 
Precautions 
Most hospitals and other medical 
facilities have standard practices for the 
prevention of infection. The wearing 
of protective clothing is recommended 
during procedurell where there is the 
possibility of a blood spurt, or where 
the staff member has exposed skin 
lesions. -
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Depending upon the type of work, it 
may be necessary to wear gloves, a 
mask and eye protection. It is not 
necessary to wear protective clothing 
for routine treatments when there is no 
likelihood of blood or secretions 
coming into direct contact with the 
staff member; for example, when 
providing physical fitness activities or 
manipulative therapy. 
Reconunended procedures for staff 
working with infected patients or 
infected material include the proper 
disposal of protective clothing and the 
maintenance of hygiene. Staff are 
instructed to place removed clothing 
into a separate, identified container 
and thoroughly wash their hands 
immediately on completion of treat-
ment of an infected person and after 
removing protective clothing. If a staff 
member's hands come into contact 
with contaminated blood or secretions, 
they should be washed immediately. 
Spills of blood Or secretions should 
be Cleaned up promptly utilising the 
hospital-approved disinfectant, All 
work surfaces should be cleaned any 
time potentially infectious materials 
have been placed on them. 
The probability of infection from 
contaminated pins used for skin 
sensitivity tests is low butphysiother-
apists should act prudently and dispose 
of unclean pins in puncture-resistant 
containers. Standard sterilisation or 
disinfection procedures are adequate 
for decontamination of HIV -infected 
materials. . 
Physiotherapists in private practice 
should exercise the same precautions. 
Hospital-strength disinfectant or even 
ordinary household bleach is sufficient 
for cleaning work surfaces. For the 
disposal of contaminated sharps, 
practitioners may obtain puncture-
resistantcontainets from the state 
health department, which will also 
arrange pick-up and disposal. At no 
time should sharp instruments be 
disposed of in ordinary waste bins or 
garbage bags. 
All precautions employed for the 
prevention of the transmission of 
Hepatitis B are more than adequate for 
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the prevention of transmission of lllV. 
PhY$iotherapy for health· 
maintenance in the HIV-infected 
patient 
It has been demonstrated that the 
appearance of opportunistic infections 
in the HIV antibody positive person is 
delayed when rigorous health mainte-
nance procedures are adopted (De-
laney 1988). Physiotherapists are very 
well placed to design physical health 
maintenance schedules to integrate 
with other aspects of a healthier 
lifestyle for the infected person. 
Fatigue is a factor and a balanced 
program of exercise and rest should be 
planned. 
Holistic health care as a preventative 
measure has assumed a significance 
with HIV infection that exceeds 
previous perceptions of its value. This 
is due to the vulnerability of the 
infected person to opportunistic 
infections, the need to maintain the 
integrity of the immune system for as 
long as possible,and the anticipated 
foreshortened life span. Strategies for 
maintaining an optimal health statuS 
are, therefore, critical. 
"Quit" strategies for smokers, the 
reduction of alcohol intake, drug 
rehabilitation procedures and attention 
to nutrition should be integrated with 
a fitness program. Total health care 
management, including counselling 
and education for reducing the risk of 
spread, should be tailored to the 
patient's lifestyle and social environ-
ment. 
This comprehensive program should 
be buttressed through professional 
counselling and self-help support 
groups. 
For patients in Groups n, ill andW, 
appropriate physiotherapy procedures 
are indicated according to the nature 
of infections. However, a program of 
general fitness should be continued 
within the patient's capacities. 
It has been demonstrated that mild 
daily exercise has both physical and 
psychological benefits for all but the 
most severely sick patients (Green 
1988). 
The psychological impact ofHIV 
infection and AIDS is extensively 
documented (Black 1986, Deuchar 
1984). 
Physical fitness regimes provide an 
element of positivism for the patient. 
Contact with professionals who 
support an optimistic outlook for 
quality of life is an essential element in 
overall health maintenance. 
Pulmonary manifestation of AIDS 
and phpiother.apy treatment 
Pneumocystis carinii pneumonia is the 
most common pulmonary infection 
found in AIDS patients, accounting for 
about 85 per cent of all AIDS-related 
lung infections (Millar 1987). Patients 
complain of breathlessness and a dry 
cough. The administration of 3 per 
.cent saline through a nebuliser helps 
sputum production. 
Tuberculosis and bacterial pneum-
onia account for most of the remaining 
25 per cent of AIDS-related lung 
infections. Fever, cough and pleuritic 
pain may be presenting symptoms. 
Cytomegalovirus occurs rarely in 
isolation in AIDS patients and is most 
often found in conjunction with 
pneumocystis carinii. 
AIDS-related pneumonia is treated 
with appropriate antibiotics. Recurrent 
episodes are anticipated and statistics 
show a life expectancy of approx-
imately two years. It is anticipated, 
however, that these figures will im-
prove as, with the recogllition of 
earlier signs and symptOms, patients 
are presenting earlier and, with in-
creased research, treatment options 
expand. 
It has been stated that patients who 
go into respiratory failure rarely 
respond to mechanical ventilation 
(Millar 1987). 
Routine physiotherapy for the 
clearing oflung secretions is appropri-
ate. Barrier nursing procedures are 
generally recommended, however the 
only risk is if the patient is likely to 
bleed directly onto an open wound or 
mucous membrane. 
Neurological manife$tations and 
physiotherapy 
The diagnosis and treatment ofHW 
infection and AIDS is in a constant 
state of development. This is espe-
cially true of AIDS-related neuro-
pathologies. As earlier diagnosis, im-
proved prognosis and new treatments 
are introduced, it is inevitable that 
physiotherapy will have a role in the 
treatment of some of the neurological 
conditions associated with HN 
infection. 
Neurological involvement may be 
caused by opportunistic infections, by 
tumours, or by the primary neuro-
logical effects of HIV destroying cells 
in the central nervous system. 
Neurological manifestations of AIDS 
generally start with cognitive changes. 
Common motor symptoms are loss of 
balance, weakness in the legs, ataxic 
gait and deterioration in handwriting. 
Temporary facial palsy has also been 
reported (Rosenblum et aI1988). 
With regard to peripheral neuro-
pathy, cranial neuropathy or space 
occupying lesions, the indications for 
physiotherapy and the procedures 
employed should be no different from 
those utilised for similar lesions 
through other causes. 
It is prudent, however, for the 
physiotherapist to exercise caution 
with those patients who suffer AIDS-
related dementia which is sometimes 
expressed in aggressive behaviour. 
For a more detailed account of 
neurological conditions associated with 
AIDS, the reader is referred to 
Rosenblum et al (1988). 
Summary 
HN infection and AIDS are relevant 
to physiotherapists both as direct care 
providers and in terms of occupational 
health and safety. 
The misinformation and stigma 
associated with HN infection and 
AIDS results in confusion for profes-
sionals and the general public. 
The better informed we all are, the 
greater the chances for reducing the 
spread of the infection and for the 
provision of compassionate treatment. 
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